Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) Sees Significant Decline in Short Interest

Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) saw a large decrease in short interest in the month of October. As of October 31st, there was short interest totalling 700 shares, a decrease of 22.2% from the October 15th total of 900 shares. Based on an average daily trading volume, of 4,000 shares, the days-to-cover ratio is currently 0.2 days.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Stock Up 0.5 %

Shares of NASDAQ HROWL opened at $25.38 on Friday. Harrow Health, Inc. 8.625% Senior Notes due 2026 has a 12 month low of $22.29 and a 12 month high of $25.73. The firm’s 50 day simple moving average is $25.43 and its 200-day simple moving average is $25.24.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 31st. Stockholders of record on Tuesday, October 15th were paid a dividend of $0.5391 per share. The ex-dividend date was Tuesday, October 15th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 8.50%.

About Harrow Health, Inc. 8.625% Senior Notes due 2026

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.